Quanterix Corporation QTRX 深 沪
已收盘 07-02 16:00:00 美东时间
4.33
-0.010
-0.23%
华盛通- 最 高4.44
- 今 开4.38
- 成交量 45.63万股
- 最 低 4.22
- 昨 收 4.34
- 总市值 2.04亿
- 52周最高 8.77
- 市盈率 静 --
- 换手率 0.97%
- 52周最低 2.395
- 委 比 -75.45%
- 总股本 4710.60万
- 历史最高 92.57
- 量 比 0.29
- 振 幅 5.07%
- 历史最低 2.395
- 每 手 1
- 风险率 1.40%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Quanterix Stock Is Popping In Pre-Market: Here's Why
Quanterix Corp. (NASDAQ:QTRX) shares surged 5.28% to $3.39 in pre-market trading on Wednesday, after the prior day’s 7.74% decline. What Investors Are Watching The after-hours rally follows Securities and Exchange Commission Tuesday filings disclosing outgoing Chief Financial Officer Vandana Sriram ...
06-24 16:39
Quanterix Appoints Jason Faessler CFO, Effective June 22
Quanterix Corporation (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced the appointment of Jason Faessler as the Company's new Chief
06-09 20:07
战略升级，共拓新境｜英诺特与Quanterix深化合作，Simoa技术拓展至感染...
2026年5月20日，北京英诺特生物技术股份有限公司（以下简称“英诺特”）与美国Quanterix Corporation（以下简称“Quanterix”）签署...
05-25 14:44
Quanterix Appoints CFO Vandana Sriram Plans To Depart
Quanterix Corporation (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that Vandana Sriram, its Chief Financial Officer ("CFO") will
05-13 04:12
美股大行评级 | 绩后暴跌10%，ARM仍获高盛、富国银行等多家大行上调目标价；康宁、优步、飞塔信息、西维斯、Agilon Health等获多家大行上调目标价
今日重点评级关注：Citizens：维持BioCryst制药"跑赢大市"评级，目标价从25美元升至28美元；富国银行：维持曼恩凯德生物医疗"超配"评级，目标价从8美元升至10美元
05-08 12:05
TD Cowen Maintains Hold on Quanterix, Lowers Price Target to $4
TD Cowen analyst Dan Brennan maintains Quanterix (NASDAQ:QTRX) with a Hold and lowers the price target from $7 to $4.
05-08 03:46
Quanterix shares are trading lower after the company reported mixed Q1 financial results.
Quanterix shares are trading lower after the company reported mixed Q1 financia...
05-07 22:57
Earnings Scheduled For May 6, 2026
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
Quanterix Affirms FY2026 Sales Guidance of $169.000M-$174.000M vs $170.887M Est
Quanterix (NASDAQ:QTRX) affirms FY2026 sales outlook from $169.000 million-$174.000 million to $169.000 million-$174.000 million vs $170.887 million estimate.
05-07 04:03
Quanterix Q1 EPS $(0.37) Beats $(0.45) Estimate, Sales $36.415M Miss $37.221M Estimate
Quanterix (NASDAQ:QTRX) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(0.45) by 17.78 percent. This is a 30.19 percent increase over losses of $(0.53) per share from the
05-07 04:02
